Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-24-021193
Filing Date
2024-12-26
Accepted
2024-12-26 08:00:16
Documents
10
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6990
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5670
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 3685
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 4501
5 GRAPHIC exhibit99-2xu001.jpg GRAPHIC 4353
6 GRAPHIC exhibit99-2xu002.jpg GRAPHIC 3097
7 GRAPHIC exhibit99-2xu003.jpg GRAPHIC 3386
8 GRAPHIC exhibit99-2xu004.jpg GRAPHIC 5472
9 GRAPHIC exhibit99-3xu001.jpg GRAPHIC 2999
10 GRAPHIC exhibit99-3xu002.jpg GRAPHIC 5154
  Complete submission text file 0001062993-24-021193.txt   56524
Mailing Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4
Business Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4 (732) 300-3046
Medicus Pharma Ltd. (Filer) CIK: 0001997296 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42408 | Film No.: 241576312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)